“…Lead may act as a calcium analog in neurons with exposure inhibiting glutamate release through binding to the NMDA receptor in an age-dependent and region specific manner (Guilarte TR, 1994), which would result in structural and functional differences despite uniform concentrations within the brain. Lead alters white matter via expression of genes essential to myelin formation (Deng W and Poretz RD, 2001, Zawia NH and Harry GJ, 1995), delayed myelin accumulation (Toews AD, 1983, Toews AD, 1980), delayed differentiation of oligodendrocyte progenitors (Deng W and Poretz RD, 2002,), disordered oligodrocyte architecture (Dabrowska-Bouta B, 1999), structural changes within the myelin sheath and disintegration of the multi-lamellar structure (Dabrowska-Bouta B, 2008) and astrogliosis (Selvin-Testa A, 1994, Struzynska L, 2001, Struzynska L, 2007). In exposing the immature rat brain to prolonged lead exposure, Struzynska demonstrated glial cell activation occurs with the elevation of GFAP and S-100βproteins, accompanied by increased cytokine production and evidence of axonal damage (Struzynska L, 2007).…”